HOME >> BIOLOGY >> NEWS
Cholesterol could be key to treating fetal alcohol syndrome

DURHAM, N.C. -- Small amounts of alcohol can interfere with the growth of a fetus, but added cholesterol may help prevent a wide array of neurological and physical defects from alcohol exposure, according to a new study in laboratory fish.

Cholesterol is so important to fetal development that pregnant women who do not have high enough cholesterol levels are at increased risk of having babies with developmental problems, even without consuming alcohol. Researchers at Duke University Medical Center, led by Yin-Xiong Li, MD., Ph.D., found that alcohol, even in small amounts, blocks the ability of cholesterol to orchestrate the complex series of events involved in regulating cell fates and organ development in the embryo. Encouragingly, the researchers also found that giving supplemental cholesterol to zebrafish embryos exposed to alcohol restored normal development.

Fetal alcohol syndrome is a term to describe an array of developmental defects affecting the nervous and cardiovascular systems. The syndrome also can lead to growth retardation, facial abnormalities and lowered mental functioning. It is estimated that approximately 100 babies are born in the United States each day with some degree of alcohol induced birth defects, at an annual cost of $10 billion to the health care system.

What alcohol does is interfere with a precisely orchestrated biochemical signaling pathway that guides fetal development. Cholesterol is essential for a single pathway that governs the pattern of tissue development and it is vulnerable to the effects of alcohol.

"This new insight into the molecular basis of fetal alcohol syndrome could have far-reaching implications and suggests new prenatal care that might prevent the developmental defects caused by alcohol consumed during pregnancy," Li said.

The researchers published the findings in the March 2007 issue of the journal Laboratory Investigation. The research was supported by the Nati
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
8-Mar-2007


Page: 1 2

Related biology news :

1. Cholesterol implicated in progression of fatty liver disease
2. Cholesterol gets thumbs up for role in digit development
3. Cholesterol-lowering foods most effective when combined, U of T study
4. Cholesterol-lowering drugs not associated with reduced colorectal cancer risk
5. Cholesterol-regulating protein maintains fat-storage, fat-burning balance
6. Newly created cancer stem cells could aid breast cancer research
7. New system of wastewater treatment could reduce the size of treatment plants by half
8. Discovery of new protein could provide new understanding of male fertility
9. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
10. How a pain in the neck could be bad for your blood pressure
11. Synchrotron could help save the Tassie devil

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/13/2020)... ... June 11, 2020 , ... Bode Technology (Bode), ... forensic genealogy team. Bode’s Forensic Genealogy Service (FGS) continues to deliver ... analysis methods. The team has added experienced genealogists, each having over a decade ...
(Date:6/11/2020)... ... June 09, 2020 , ... Superior Controls, Inc. , an E Technologies ... for the life sciences industry, is pleased to announce the recent hiring of Ray ... company’s Seabrook, New Hampshire office. In his new role, Boudreau will use his ...
(Date:6/5/2020)... ... June 04, 2020 , ... “Although we are disappointed to have to ... attendees, staff, and the public. We remain committed to creating a global platform ... virtually,” said Julie Sutcliffe, President of WMIS. , The abstract deadline ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... WESTMINSTER, Colo. (PRWEB) , ... ... ... providers of expert tissue data insights, today announced that the launch of ... PD-L1 results along with data about the tumor microenvironment (TME). , “Flagship’s ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda ... treating cancer, today announced the company has entered a license agreement with Roswell ... provides Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, the ... today that Derek Fournier has been appointed CEO and President. Founder and former ... immediately. , “DeCurtis Corporation has been on an incredible journey for the ...
(Date:6/23/2020)... Ore. (PRWEB) , ... June 23, 2020 , ... ... of innovative CNS therapies, today announced that it has filed an Investigational New ... a Phase 2b clinical trial of its lead drug candidate NBTX-001 in patients ...
Breaking Biology Technology:
Cached News: